DGAP-Adhoc: Geratherm Medical AG: High growth in sales and results in the first half of 2020, especially in the second quarter
DGAP-Ad-hoc: Geratherm Medical AG / Key word(s): Half Year Results Publication of an insider information pursuant to article 17 of MAR Geratherm Medical: High growth in sales and results in the first half of 2020, especially in the second quarter - Strong international demand for Geratherm medical devices for Corona prevention - Sales revenues 13.9 million EUR + 29.4 %, second quarter +71.5 % - EBITDA 2,052 kEUR + 36.0 %, second quarter 1,381 kEUR - EBIT 1,454 kEUR +54.2 %, second quarter 1,082 kEUR - EBIT margin 10.5 %, second quarter 14.2 % - Results of normal business activity 1,403 kEUR + 46.5 %, second quarter 1,055 kEUR - Earnings per share 21 cents (previous year: 11 cents), second quarter 15 cents Geratal, 12 August 2020 - In the course of the international spread of the Corona pandemic, there was a high demand for Geratherm devices during the last months. There was a growth in sales for the entire company of +71.5 % in the second quarter. All the business segments indicated a high growth in sales. The demand is still higher than the supply, so that we can assume a continuation of the positive corporate development. The detailed half-year report will be published on 20 August 2020. Geratherm Medical AG
Contact: Dr. Gert Frank
12-Aug-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Geratherm Medical AG |
Fahrenheitstraße 1 | |
98716 Geschwenda | |
Germany | |
Phone: | +49 (0)36205 98-0 |
Fax: | +49 (0)36205 98-1 15 |
E-mail: | [email protected] |
Internet: | www.geratherm.com |
ISIN: | DE0005495626 |
WKN: | 549562 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 1116587 |
End of Announcement | DGAP News Service |
|
1116587 12-Aug-2020 CET/CEST